{"transactions":[{"id":4635102,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T01:02:00.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":77390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a grant of Restricted Stock. The Restricted Stock was granted to the Reporting Person pursuant to the Compensation Agreement. The Restricted Stock vested pursuant to the terms of the Compensation Agreement."}],"balance_after":210845,"source":{"system":"sec-edgar","filing":"0001493152-26-045586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045586/ownership.xml","form_type":"4"}},{"id":4635101,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T01:02:00.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":16620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock. The Restricted Stock was granted to the Reporting Person pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person (the \"Compensation Agreement\") providing for quarterly grants equal to $60,000. The Restricted Stock vested pursuant to the terms of the Compensation Agreement."}],"balance_after":133455,"source":{"system":"sec-edgar","filing":"0001493152-26-045586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045586/ownership.xml","form_type":"4"}},{"id":4635118,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-10-03T01:00:28.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":100000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-26-045576","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045576/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-15"}},{"id":4635117,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T01:00:28.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":16806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a grant of RSUs issued pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person. The RSUs vested immediately upon grant on April 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of RSUs issued pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person. The RSUs vested immediately upon grant on April 13, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount Beneficially Owned Following Transaction has been corrected from 262,191 to 116,835."}],"balance_after":116835,"source":{"system":"sec-edgar","filing":"0001493152-26-045576","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226045576/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-15"}},{"id":778781,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":47269,"kind":"person","name":"Voss Chelsea Sierra","position":1,"cik":"0002108237","reported_name":"Voss Chelsea Sierra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-05-14T21:33:52.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":1753,"price":3.15,"value":5521.95,"ownership":{"direct":false,"nature":"By Roth IRA"},"balance_after":61555,"source":{"system":"sec-edgar","filing":"0001493152-26-023217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226023217/ownership.xml","form_type":"4"}},{"id":808256,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52420,"kind":"person","name":"Friscia Stephen","position":1,"cik":"0002028845","reported_name":"Friscia Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-15T22:29:11.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-016910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028845/000149315226016910/ownership.xml","form_type":"4"}},{"id":808089,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":47269,"kind":"person","name":"Voss Chelsea Sierra","position":1,"cik":"0002108237","reported_name":"Voss Chelsea Sierra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-15T22:29:11.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-016913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226016913/ownership.xml","form_type":"4"}},{"id":808249,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52419,"kind":"person","name":"Glass Mitchell","position":1,"cik":"0002023649","reported_name":"Glass Mitchell","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-15T22:29:10.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-016911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023649/000149315226016911/ownership.xml","form_type":"4"}},{"id":808159,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-15T22:29:10.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-016914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315226016914/ownership.xml","form_type":"4"}},{"id":808085,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-15T22:29:09.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-26-016912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226016912/ownership.xml","form_type":"4"}},{"id":808084,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2026-04-15T22:29:09.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":162162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\") issued pursuant to an executive compensation agreement, dated April 13, 2026, by and between the Issuer and the Reporting Person. The RSUs vested immediately upon grant on April 13, 2026."}],"balance_after":262191,"source":{"system":"sec-edgar","filing":"0001493152-26-016912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226016912/ownership.xml","form_type":"4"}},{"id":808083,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-15T22:29:09.000Z","date":"2026-04-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":5,"exercise_date":"2026-04-13","expiration_date":"2036-04-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-016909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226016909/ownership.xml","form_type":"4"}},{"id":926848,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":47269,"kind":"person","name":"Voss Chelsea Sierra","position":1,"cik":"0002108237","reported_name":"Voss Chelsea Sierra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-30T22:31:25.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":212500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were granted pursuant to the Consulting Agreement and will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is employed by or providing services to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The stock options were granted pursuant to the Consulting Agreement and will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is employed by or providing services to the Issuer through the applicable vesting dates."}],"balance_after":212500,"derivative":{"exercise_price":5.097,"expiration_date":"2036-01-16","underlying":"Common Stock","underlying_shares":212500},"source":{"system":"sec-edgar","filing":"0001493152-26-004565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226004565/ownership.xml","form_type":"4"}},{"id":926847,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":47269,"kind":"person","name":"Voss Chelsea Sierra","position":1,"cik":"0002108237","reported_name":"Voss Chelsea Sierra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-01-30T22:31:25.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a grant of RSUs issued in connection with the appointment of the Reporting Person as director of the Issuer's board of directors. The RSUs will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is employed by or providing services to the Issuer through the applicable vesting dates."}],"balance_after":239900,"source":{"system":"sec-edgar","filing":"0001493152-26-004565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226004565/ownership.xml","form_type":"4"}},{"id":926846,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":47269,"kind":"person","name":"Voss Chelsea Sierra","position":1,"cik":"0002108237","reported_name":"Voss Chelsea Sierra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-01-30T22:31:25.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":212500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\") issued pursuant to a consulting agreement, dated January 16, 2026, by and between the Issuer and the Reporting Person (the \"Consulting Agreement\"). The RSUs will vest in four substantially equal installments on each quarterly anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer through the applicable vesting dates."}],"balance_after":214900,"source":{"system":"sec-edgar","filing":"0001493152-26-004565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315226004565/ownership.xml","form_type":"4"}},{"id":996281,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc.","position":1,"cik":"0001157075","reported_name":"PharmaCyte Biotech, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2025-11-18T21:32:29.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":889865,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."},{"field":"date","element":"transactionDate","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."}],"balance_after":889865,"derivative":{"expiration_date":"2030-11-14","underlying":"Common stock, par value $0.001 per share","underlying_shares":889865},"source":{"system":"sec-edgar","filing":"0001683168-25-008517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825008517/ownership.xml","form_type":"4"}},{"id":996280,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc.","position":1,"cik":"0001157075","reported_name":"PharmaCyte Biotech, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series H Convertible Preferred Stock","published_at":"2025-11-18T21:32:29.000Z","date":"2025-09-04","kind":"purchase","planned":false,"acquired":true,"shares":889865,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."},{"field":"date","element":"transactionDate","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series H Convertible Preferred Stock is convertible into shares of common stock at a conversion price of $3.3713, subject to adjustment. The Series H Convertible Preferred Stock and warrants became convertible upon shareholder approval for the issuance of the underlying common stock at a special meeting held on November 14, 2025. The conversion rights of the Series H Convertible Preferred Stock do not expire."}],"balance_after":889865,"derivative":{"underlying":"Common stock, par value $0.001 per share","underlying_shares":889865},"source":{"system":"sec-edgar","filing":"0001683168-25-008517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825008517/ownership.xml","form_type":"4"}},{"id":998037,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52419,"kind":"person","name":"Glass Mitchell","position":1,"cik":"0002023649","reported_name":"Glass Mitchell","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, Chief Medical Off."}}],"security":"Common stock","published_at":"2025-11-17T22:30:03.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":11420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the \"Plan Amendment\"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001493152-25-023937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023649/000149315225023937/ownership.xml","form_type":"4"}},{"id":997707,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-11-17T22:30:01.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":22839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the \"Plan Amendment\"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance."}],"balance_after":25024,"source":{"system":"sec-edgar","filing":"0001493152-25-023936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315225023936/ownership.xml","form_type":"4"}},{"id":998738,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2025-11-15T01:16:44.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":91356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the \"Plan Amendment\"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance."}],"balance_after":100029,"source":{"system":"sec-edgar","filing":"0001493152-25-023701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225023701/ownership.xml","form_type":"4"}},{"id":999072,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52420,"kind":"person","name":"Friscia Stephen","position":1,"cik":"0002028845","reported_name":"Friscia Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-11-15T01:16:08.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":22839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the \"Plan Amendment\"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-25-023699","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028845/000149315225023699/ownership.xml","form_type":"4"}},{"id":998739,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-11-15T01:15:28.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the \"Plan Amendment\"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-25-023697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225023697/ownership.xml","form_type":"4"}},{"id":998729,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":73116,"kind":"person","name":"RAUCH GARY M","position":1,"cik":"0001597530","reported_name":"RAUCH GARY M","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Vice President of Finance"}}],"security":"Common stock","published_at":"2025-11-15T01:14:07.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":11420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the \"Plan Amendment\"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001493152-25-023696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225023696/ownership.xml","form_type":"4"}},{"id":1022881,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2025-10-06T21:30:05.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":8644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs vested immediately upon grant on October 3, 2025."}],"balance_after":8673,"source":{"system":"sec-edgar","filing":"0001493152-25-017132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225017132/ownership.xml","form_type":"4"}},{"id":1023491,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52420,"kind":"person","name":"Friscia Stephen","position":1,"cik":"0002028845","reported_name":"Friscia Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-10-06T21:30:03.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":2161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs vested immediately upon grant on October 3, 2025."}],"balance_after":2161,"source":{"system":"sec-edgar","filing":"0001493152-25-017129","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028845/000149315225017129/ownership.xml","form_type":"4"}},{"id":1023488,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52419,"kind":"person","name":"Glass Mitchell","position":1,"cik":"0002023649","reported_name":"Glass Mitchell","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, Chief Medical Off."}}],"security":"Common stock","published_at":"2025-10-06T21:30:02.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs vested immediately upon grant on October 3, 2025."}],"balance_after":1080,"source":{"system":"sec-edgar","filing":"0001493152-25-017130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023649/000149315225017130/ownership.xml","form_type":"4"}},{"id":1022958,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-10-06T21:30:00.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":2161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs vested immediately upon grant on October 3, 2025."}],"balance_after":2185,"source":{"system":"sec-edgar","filing":"0001493152-25-017133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315225017133/ownership.xml","form_type":"4"}},{"id":1022880,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":73116,"kind":"person","name":"RAUCH GARY M","position":1,"cik":"0001597530","reported_name":"RAUCH GARY M","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Vice President of Finance"}}],"security":"Common stock","published_at":"2025-10-06T21:29:59.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"). The RSUs vested immediately upon grant on October 3, 2025."}],"balance_after":1080,"source":{"system":"sec-edgar","filing":"0001493152-25-017131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225017131/ownership.xml","form_type":"4"}},{"id":1169039,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":73116,"kind":"person","name":"RAUCH GARY M","position":1,"cik":"0001597530","reported_name":"RAUCH GARY M","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Vice President, Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-18T20:30:15.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the employment of the Reporting Person is terminated."}],"balance_after":75000,"derivative":{"exercise_price":0.1832,"exercise_date":"2025-04-18","expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001641172-25-005425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000164117225005425/ownership.xml","form_type":"4"}},{"id":1169080,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":53590,"kind":"person","name":"RHODES IAN THOMAS","position":1,"cik":"0001612365","reported_name":"RHODES IAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-18T20:30:14.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the employment of the Reporting Person is terminated."}],"balance_after":25000,"derivative":{"exercise_price":0.1832,"exercise_date":"2025-04-18","expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001641172-25-005426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612365/000164117225005426/ownership.xml","form_type":"4"}},{"id":1169139,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52419,"kind":"person","name":"Glass Mitchell","position":1,"cik":"0002023649","reported_name":"Glass Mitchell","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-18T20:30:12.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options are subject to expiration if the employment of the Reporting Person is terminated."}],"balance_after":125000,"derivative":{"exercise_price":0.1832,"exercise_date":"2025-04-18","expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001641172-25-005424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023649/000164117225005424/ownership.xml","form_type":"4"}},{"id":1797517,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common stock","published_at":"2023-08-24T21:58:33.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.11,"value":166500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.045 to $1.15, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc., any security holder of MyMD Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001493152-23-030111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223030111/ownership.xml","form_type":"4"}},{"id":1801704,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common stock","published_at":"2023-08-18T20:21:49.000Z","date":"2023-08-17","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.1232,"value":28080.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001493152-23-029445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223029445/ownership.xml","form_type":"4"}},{"id":1860239,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:28.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-23-020795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020795/ownership.xml","form_type":"4"}},{"id":1860238,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110917,"kind":"person","name":"Kaplin Adam","position":1,"cik":"0001858042","reported_name":"Kaplin Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:27.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-020793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020793/ownership.xml","form_type":"4"}},{"id":1860237,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":112506,"kind":"person","name":"Uzonwanne Jude","position":1,"cik":"0001858040","reported_name":"Uzonwanne Jude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:24.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-020799","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020799/ownership.xml","form_type":"4"}},{"id":1860236,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:22.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-020796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020796/ownership.xml","form_type":"4"}},{"id":1860235,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:21.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-23-020798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020798/ownership.xml","form_type":"4"}},{"id":1860234,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":28964,"kind":"person","name":"EAGLE CRAIG","position":1,"cik":"0001562135","reported_name":"EAGLE CRAIG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:21.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":475000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001493152-23-020797","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020797/ownership.xml","form_type":"4"}},{"id":1860466,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:18.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-020794","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315223020794/ownership.xml","form_type":"4"}},{"id":1860233,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:18.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-020800","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020800/ownership.xml","form_type":"4"}},{"id":1924741,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-04-05T20:28:15.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) 250,000 on the date of grant; (ii) 250,000 on the first anniversary of the date of grant; and (iii) 250,000 on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":750000,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001493152-23-011040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223011040/ownership.xml","form_type":"4"}},{"id":2092047,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Common stock","published_at":"2022-12-09T01:24:04.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":10000,"price":1.53,"value":15300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.53, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc., any security holder of MyMD Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":225000,"source":{"system":"sec-edgar","filing":"0001493152-22-034969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315222034969/ownership.xml","form_type":"4"}},{"id":2492984,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-29T17:46:33.000Z","date":"2021-11-26","kind":"purchase","acquired":true,"shares":5000,"price":7.5543,"value":37771.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.70, inclusive."}],"balance_after":88775,"source":{"system":"sec-edgar","filing":"0001493152-21-029973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/ownership.xml","form_type":"4"}},{"id":2492983,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-29T17:46:33.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":3266,"price":7.0937,"value":23168.0242,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.17, inclusive."}],"balance_after":83775,"source":{"system":"sec-edgar","filing":"0001493152-21-029973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/ownership.xml","form_type":"4"}},{"id":2492982,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-29T17:46:33.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":6734,"price":6.2991,"value":42418.1394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.96, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4."}],"balance_after":80509,"source":{"system":"sec-edgar","filing":"0001493152-21-029973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029973/ownership.xml","form_type":"4"}},{"id":2494945,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Common stock","published_at":"2021-11-24T17:56:11.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":15000,"price":6.03,"value":90450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.05, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc., any security holder of MyMD Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":215000,"source":{"system":"sec-edgar","filing":"0001493152-21-029774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221029774/ownership.xml","form_type":"4"}},{"id":2541441,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110917,"kind":"person","name":"Kaplin Adam","position":1,"cik":"0001858042","reported_name":"Kaplin Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:23:37.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":600000,"derivative":{"underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-21-025613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025613/ownership.xml","form_type":"4"}},{"id":2541440,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:22:09.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-025609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025609/ownership.xml","form_type":"4"}},{"id":2541654,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:22:04.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-025608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315221025608/ownership.xml","form_type":"4"}},{"id":2541439,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":112506,"kind":"person","name":"Uzonwanne Jude","position":1,"cik":"0001858040","reported_name":"Uzonwanne Jude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:21:35.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-025606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025606/ownership.xml","form_type":"4"}},{"id":2541437,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":28964,"kind":"person","name":"EAGLE CRAIG","position":1,"cik":"0001562135","reported_name":"EAGLE CRAIG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:21:24.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-025605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025605/ownership.xml","form_type":"4"}},{"id":2541438,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:20:33.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":600000,"derivative":{"underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-21-025602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025602/ownership.xml","form_type":"4"}},{"id":2541436,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:20:24.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":600000,"derivative":{"underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-21-025601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025601/ownership.xml","form_type":"4"}},{"id":2541435,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:20:17.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":200000,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-21-025600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025600/ownership.xml","form_type":"4"}},{"id":2741790,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":28964,"kind":"person","name":"EAGLE CRAIG","position":1,"cik":"0001562135","reported_name":"EAGLE CRAIG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-23T01:29:07.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":482375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for a stock option to acquire 1,250,000 shares of common stock of a private company formerly known as \"MyMD Pharmaceuticals, Inc.\" (the \"Former Entity\") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the \"Merger\"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."}],"balance_after":482375,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":482375},"source":{"system":"sec-edgar","filing":"0001493152-21-009498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009498/ownership.xml","form_type":"4"}},{"id":2742877,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110917,"kind":"person","name":"Kaplin Adam","position":1,"cik":"0001858042","reported_name":"Kaplin Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T01:53:13.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":154360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for a stock option to acquire 400,000 shares of common stock of a private company formerly known as \"MyMD Pharmaceuticals, Inc.\" (the \"Former Entity\") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the \"Merger\"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."}],"balance_after":154360,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":154360},"source":{"system":"sec-edgar","filing":"0001493152-21-009409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009409/ownership.xml","form_type":"4"}},{"id":2742876,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-21T21:55:11.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":131750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 131,750 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 131,750 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":131750},"source":{"system":"sec-edgar","filing":"0001493152-21-009398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009398/ownership.xml","form_type":"4"}},{"id":2742875,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T21:55:11.000Z","date":"2021-04-16","kind":"tax_withholding","acquired":false,"shares":46113,"price":4.94,"value":227798.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 46,113 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 131,750 shares of RSUs on April 16, 2021."}],"balance_after":88238,"source":{"system":"sec-edgar","filing":"0001493152-21-009398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009398/ownership.xml","form_type":"4"}},{"id":2742874,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T21:55:11.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":131750,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":134351,"source":{"system":"sec-edgar","filing":"0001493152-21-009398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009398/ownership.xml","form_type":"4"}},{"id":2742873,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":112506,"kind":"person","name":"Uzonwanne Jude","position":1,"cik":"0001858040","reported_name":"Uzonwanne Jude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:55:20.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":115770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for a stock option to acquire 300,000 shares of common stock of a private company formerly known as \"MyMD Pharmaceuticals, Inc.\" (the \"Former Entity\") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the \"Merger\"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option shall vest according to the following schedule: 50% on October 26, 2021 and 50% on October 26, 2022."}],"balance_after":115770,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":115770},"source":{"system":"sec-edgar","filing":"0001493152-21-009387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009387/ownership.xml","form_type":"4"}},{"id":2742872,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":96475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a stock option to acquire 250,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":96475,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":96475},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742871,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Merger in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742870,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742869,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":38590,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in the Merger in exchange for a stock option to acquire 100,000 shares of common stock of the Former Entity at $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested and exercisable."}],"balance_after":38590,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":38590},"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2742868,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":94491,"kind":"person","name":"Chapman Christopher C JR","position":1,"cik":"0001340428","reported_name":"Chapman Christopher C JR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Med. Officer"}}],"security":"Common Stock","published_at":"2021-04-21T20:53:29.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":96475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 250,000 shares of common stock of a private company formerly known as \"MyMD Pharmaceuticals, Inc.\" (the \"Former Entity\") in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the \"Merger\"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share."}],"balance_after":96475,"source":{"system":"sec-edgar","filing":"0001493152-21-009385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009385/ownership.xml","form_type":"4"}},{"id":2743870,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T01:44:21.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share in connection with the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are jointly held by the reporting person and Jennifer Rivard as trustees for the Paul Rivard and Jennifer Rivard Revocable Living Trust."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009302/ownership.xml","form_type":"4"}},{"id":2743869,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":110261,"kind":"person","name":"Rivard Paul","position":1,"cik":"0001857479","reported_name":"Rivard Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Operations, GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T01:44:21.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":77180,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for a stock option to acquire 200,000 shares of common stock of a private company formerly known as \"MyMD Pharmaceuticals, Inc.\" (the \"Former Entity\") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the \"Merger\"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested and exercisable."}],"balance_after":77180,"derivative":{"exercise_price":2.5913,"expiration_date":"2023-04-16","underlying":"Common Stock","underlying_shares":77180},"source":{"system":"sec-edgar","filing":"0001493152-21-009302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009302/ownership.xml","form_type":"4"}},{"id":2743868,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-21T01:35:17.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":109500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":109500},"source":{"system":"sec-edgar","filing":"0001493152-21-009294","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009294/ownership.xml","form_type":"4"}},{"id":2743867,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T01:35:17.000Z","date":"2021-04-16","kind":"tax_withholding","acquired":false,"shares":38325,"price":4.94,"value":189325.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 38,325 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 109,500 shares of RSUs on April 16, 2021."}],"balance_after":71175,"source":{"system":"sec-edgar","filing":"0001493152-21-009294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009294/ownership.xml","form_type":"4"}},{"id":2743866,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T01:35:17.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":109500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":112101,"source":{"system":"sec-edgar","filing":"0001493152-21-009294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009294/ownership.xml","form_type":"4"}},{"id":2743966,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-21T01:32:06.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":109500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":109500},"source":{"system":"sec-edgar","filing":"0001493152-21-009291","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315221009291/ownership.xml","form_type":"4"}},{"id":2743965,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T01:32:06.000Z","date":"2021-04-16","kind":"tax_withholding","acquired":false,"shares":38325,"price":4.94,"value":189325.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 38,325 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 109,500 shares of RSUs on April 16, 2021."}],"balance_after":71175,"source":{"system":"sec-edgar","filing":"0001493152-21-009291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315221009291/ownership.xml","form_type":"4"}},{"id":2743964,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T01:32:06.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":109500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":112101,"source":{"system":"sec-edgar","filing":"0001493152-21-009291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315221009291/ownership.xml","form_type":"4"}},{"id":2743891,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":140150,"kind":"person","name":"SCHROEDER ROBERT C","position":1,"cik":"0001268331","reported_name":"SCHROEDER ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-20T21:37:41.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":43930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 43,930 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 43,930 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":43930},"source":{"system":"sec-edgar","filing":"0001493152-21-009297","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1268331/000149315221009297/ownership.xml","form_type":"4"}},{"id":2743890,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":140150,"kind":"person","name":"SCHROEDER ROBERT C","position":1,"cik":"0001268331","reported_name":"SCHROEDER ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-20T21:37:41.000Z","date":"2021-04-16","kind":"tax_withholding","acquired":false,"shares":14694,"price":4.94,"value":72588.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represent 14,694 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 43,930 shares of RSUs on April 16, 2021."}],"balance_after":29236,"source":{"system":"sec-edgar","filing":"0001493152-21-009297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1268331/000149315221009297/ownership.xml","form_type":"4"}},{"id":2743889,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":140150,"kind":"person","name":"SCHROEDER ROBERT C","position":1,"cik":"0001268331","reported_name":"SCHROEDER ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-20T21:37:41.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":43930,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":43930,"source":{"system":"sec-edgar","filing":"0001493152-21-009297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268331/000149315221009297/ownership.xml","form_type":"4"}},{"id":3033202,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-09-11T22:29:17.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":219000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."}],"balance_after":219000,"derivative":{"underlying":"Common Stock","underlying_shares":219000},"source":{"system":"sec-edgar","filing":"0001493152-20-017674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315220017674/ownership.xml","form_type":"4"}},{"id":3033056,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-09-11T22:27:11.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":219000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."}],"balance_after":219000,"derivative":{"underlying":"Common Stock","underlying_shares":219000},"source":{"system":"sec-edgar","filing":"0001493152-20-017672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220017672/ownership.xml","form_type":"4"}},{"id":3033055,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman and President"}}],"security":"Restricted Stock Unit","published_at":"2020-09-11T22:22:00.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":263500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting Person was granted 263,500 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting Person was granted 263,500 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."}],"balance_after":263500,"derivative":{"underlying":"Common Stock","underlying_shares":263500},"source":{"system":"sec-edgar","filing":"0001493152-20-017668","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220017668/ownership.xml","form_type":"4"}},{"id":3033087,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":140150,"kind":"person","name":"SCHROEDER ROBERT C","position":1,"cik":"0001268331","reported_name":"SCHROEDER ROBERT C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-09-11T18:24:43.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":87860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting Person was granted 87,860 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting Person was granted 87,860 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."}],"balance_after":87860,"derivative":{"underlying":"Common Stock","underlying_shares":87860},"source":{"system":"sec-edgar","filing":"0001493152-20-017670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268331/000149315220017670/ownership.xml","form_type":"4"}},{"id":3231832,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, no par value (\"Common Stock\")","published_at":"2020-03-03T14:55:13.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":638,"price":2.81,"value":1792.78,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.82 to $2.83, inclusive.  The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":240305,"source":{"system":"sec-edgar","filing":"0001393825-20-000097","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000097/primary_doc.xml","form_type":"4"}},{"id":3243718,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T16:06:50.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":15300,"price":2.72,"value":41616.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.72 to $2.80, inclusive.  The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":240943,"source":{"system":"sec-edgar","filing":"0001393825-20-000096","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000096/primary_doc.xml","form_type":"4"}},{"id":3243717,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, no par value (\"Common Stock\")","published_at":"2020-02-27T16:06:50.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":13000,"price":2.92,"value":37960.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.87 to $2.93, inclusive.  The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":256243,"source":{"system":"sec-edgar","filing":"0001393825-20-000096","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000096/primary_doc.xml","form_type":"4"}},{"id":3316219,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-20","kind":"purchase","acquired":true,"shares":8000,"price":3.02,"value":24160.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":269243,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316218,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-19","kind":"purchase","acquired":true,"shares":2700,"price":3.08,"value":8316.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":261243,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316217,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-18","kind":"purchase","acquired":true,"shares":7500,"price":3.07,"value":23025.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":258043,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316216,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-17","kind":"purchase","acquired":true,"shares":3000,"price":3.03,"value":9090.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":251043,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316215,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-16","kind":"purchase","acquired":true,"shares":5000,"price":3.07,"value":15350.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":248043,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316214,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-13","kind":"purchase","acquired":true,"shares":6000,"price":3.02,"value":18120.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":243043,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316213,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-12","kind":"purchase","acquired":true,"shares":20600,"price":2.98,"value":61388.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":237043,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316212,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-11","kind":"purchase","acquired":true,"shares":6019,"price":3.05,"value":18357.95,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":216443,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316211,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-11","kind":"purchase","acquired":true,"shares":26406,"price":3.1,"value":81858.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":210424,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316210,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-10","kind":"purchase","acquired":true,"shares":30000,"price":2.97,"value":89100.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":184018,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316209,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-09","kind":"purchase","acquired":true,"shares":50000,"price":2.99,"value":149500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":154018,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3316208,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":106903,"kind":"organization","name":"Hudson Bay Capital Management LP","position":1,"cik":"0001393825","reported_name":"Hudson Bay Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109726,"kind":"person","name":"Gerber Sander","position":2,"cik":"0001416593","reported_name":"Gerber Sander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, no par value (\"Common Stock\")","published_at":"2020-01-07T17:32:23.000Z","date":"2019-12-09","kind":"purchase","acquired":true,"shares":19353,"price":2.96,"value":57284.88,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Hudson Bay Master Fund, Ltd. (the \"Fund\"). Hudson Bay Capital Management LP (the \"Investment Manager\") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein."}],"balance_after":104018,"source":{"system":"sec-edgar","filing":"0001393825-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416593/000139382520000002/primary_doc.xml","form_type":"4"}},{"id":3322329,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-01-04T00:11:04.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5201},"source":{"system":"sec-edgar","filing":"0001493152-20-000166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220000166/ownership.xml","form_type":"4"}},{"id":3322328,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-01-04T00:11:04.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."}],"balance_after":5201,"source":{"system":"sec-edgar","filing":"0001493152-20-000166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220000166/ownership.xml","form_type":"4"}},{"id":3323090,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-01-04T00:10:28.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5201},"source":{"system":"sec-edgar","filing":"0001493152-20-000165","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315220000165/ownership.xml","form_type":"4"}},{"id":3323089,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":52400,"kind":"person","name":"White Billy Joe","position":1,"cik":"0001546805","reported_name":"White Billy Joe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-04T00:10:28.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."}],"balance_after":5201,"source":{"system":"sec-edgar","filing":"0001493152-20-000165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1546805/000149315220000165/ownership.xml","form_type":"4"}}],"next_cursor":"2020-01-04T00:10:28.000000Z,3323089"}